Ensysce Biosciences Inc. (ENSC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ensysce Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.45
+0.53% today
Market cap
$9M
Overall quality
45/100
Kronos AI 30-day
—
Ensysce Biosciences Inc. (ENSC) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $9M. It trades at $0.45, up 0.53% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 1 analysts' average target of $2.00 implies +344.4% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $2.00 |
| Low – high | $2.00 – $2.00 |
| Analysts | 1 |
| Upside to average | +344.4% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 6 |
| Solvency | 71 |
| Growth | 57 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.